HMD 3.70% 2.8¢ heramed limited

Jianmin Pharma, page-9

  1. 3,092 Posts.
    lightbulb Created with Sketch. 950
    Not quite what we thought...so the sale of shares between entities.

    That would appear to be below the threshold for a significant shareholder.

    (MT Newswires) -- Jianmin Pharmaceutical Group (SHA:600976) will acquire a 4.47% stake in Australia-listed Hera Med (ASX:HMD) for 8.4 million yuan from Huali Pharmaceutical Group.

    The Chinese drugmaker will buy 10.9 million shares in Hera Med, according to a filing on Wednesday.

    Jianmin issued a risk warning about the transaction as it involves cross-border equity transfer, which could be subject to regulatory requirements.


    Price (RMB): ¥49.04, Change: ¥-0.16, Percent Change: -0.33%


 
watchlist Created with Sketch. Add HMD (ASX) to my watchlist
(20min delay)
Last
2.8¢
Change
0.001(3.70%)
Mkt cap ! $11.01M
Open High Low Value Volume
2.8¢ 2.9¢ 2.8¢ $10.43K 371.1K

Buyers (Bids)

No. Vol. Price($)
2 262786 2.8¢
 

Sellers (Offers)

Price($) Vol. No.
2.9¢ 107433 1
View Market Depth
Last trade - 14.35pm 21/06/2024 (20 minute delay) ?
HMD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.